Literature DB >> 26400790

Characterization of Achromobacter Species in Cystic Fibrosis Patients: Comparison of bla(OXA-114) PCR Amplification, Multilocus Sequence Typing, and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

Elenice R A Rodrigues, Alex G Ferreira, Robson S Leão, Cassiana C F Leite, Ana Paula Carvalho-Assef, Rodolpho M Albano, Elizabeth A Marques.   

Abstract

Molecular methodologies were used to identify 28 Achromobacter spp. from patients with cystic fibrosis (CF). Multilocus sequence typing (MLST) identified 17 Achromobacter xylosoxidans isolates (all bla(OXA-114) positive), nine Achromobacter ruhlandii isolates (all bla(OXA-114) positive), one Achromobacter dolens isolate, and one Achromobacter insuavis isolate. All less common species were misidentified as A. xylosoxidans by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Chronic colonization by clonally related A. ruhlandii isolates was demonstrated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26400790      PMCID: PMC4652089          DOI: 10.1128/JCM.02197-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment.

Authors:  Winnie Ridderberg; Karen E M Bendstrup; Hanne V Olesen; Søren Jensen-Fangel; Niels Nørskov-Lauritsen
Journal:  J Cyst Fibros       Date:  2011-08-10       Impact factor: 5.482

2.  Acceptance criteria for identification results of Gram-negative rods by mass spectrometry.

Authors:  Annelies De Bel; Ingrid Wybo; Kristof Vandoorslaer; Paul Rosseel; Sabine Lauwers; Denis Piérard
Journal:  J Med Microbiol       Date:  2011-01-13       Impact factor: 2.472

3.  A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species.

Authors:  Theodore Spilker; Peter Vandamme; John J Lipuma
Journal:  J Clin Microbiol       Date:  2012-07-11       Impact factor: 5.948

4.  Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans.

Authors:  Winnie Ridderberg; Mikala Wang; Niels Nørskov-Lauritsen
Journal:  J Clin Microbiol       Date:  2012-06-06       Impact factor: 5.948

5.  Advantages of using matrix-assisted laser desorption ionization-time of flight mass spectrometry as a rapid diagnostic tool for identification of yeasts and mycobacteria in the clinical microbiological laboratory.

Authors:  Jonathan H K Chen; Wing-Cheong Yam; Antonio H Y Ngan; Ami M Y Fung; Wai-Lan Woo; Mei-Kum Yan; Garnet K Y Choi; Pak-Leung Ho; Vincent C C Cheng; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

6.  Presence of OXA-type enzymes in Achromobacter insuavis and A. dolens.

Authors:  German Traglia; Mariana Papalia; Marisa Almuzara; Gabriel Gutkind; Daniela Centrón; Carlos Vay; Marcela Radice; María Soledad Ramírez
Journal:  Curr Microbiol       Date:  2014-06-04       Impact factor: 2.188

7.  Early treatment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis.

Authors:  M Wang; W Ridderberg; C R Hansen; N Høiby; S Jensen-Fangel; H V Olesen; M Skov; L E Lemming; T Pressler; H K Johansen; N Nørskov-Lauritsen
Journal:  J Cyst Fibros       Date:  2013-05-31       Impact factor: 5.482

8.  OXA-258 from Achromobacter ruhlandii: a species-specific marker.

Authors:  Mariana Papalia; Marisa Almuzara; Daniela Cejas; German Traglia; Maria Soledad Ramírez; Laura Galanternik; Carlos Vay; Gabriel Gutkind; Marcela Radice
Journal:  J Clin Microbiol       Date:  2013-03-06       Impact factor: 5.948

9.  Performance of mass spectrometric identification of bacteria and yeasts routinely isolated in a clinical microbiology laboratory using MALDI-TOF MS.

Authors:  Weiping Wang; Haiyan Xi; Mei Huang; Jie Wang; Ming Fan; Yong Chen; Haifeng Shao; Xiaojun Li
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

10.  Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients.

Authors:  A Lambiase; M R Catania; M Del Pezzo; F Rossano; V Terlizzi; A Sepe; V Raia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-31       Impact factor: 3.267

View more
  6 in total

1.  Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study.

Authors:  B D Edwards; J Greysson-Wong; R Somayaji; B Waddell; F J Whelan; D G Storey; H R Rabin; M G Surette; M D Parkins
Journal:  J Clin Microbiol       Date:  2017-04-26       Impact factor: 5.948

2.  Distribution of Achromobacter Species in 12 French Cystic Fibrosis Centers in 2020 by a Retrospective MALDI-TOF MS Spectrum Analysis.

Authors:  Thomas Garrigos; Manon Dollat; Arnaud Magallon; Anaïs Folletet; Julien Bador; Maryam Abid; Marlène Amara; Clémence Beauruelle; Olivier Belmonte; Pierre Boyer; Emilie Cardot-Martin; Anne-Gaëlle Cauchie; Sylvie Colin de Verdière; Claire Daurel; Cécile Gaudru; Farida Hamdad; Geneviève Héry-Arnaud; Baptiste Hoellinger; Claudie Lamoureux; Marie-Frédérique Lartigue; Damasie Malandain; Océane Marchand; Caroline Piau; Sandrine Picot; Hélène Revillet; Zeina Sabouni; Catherine Neuwirth; Lucie Amoureux
Journal:  J Clin Microbiol       Date:  2022-05-05       Impact factor: 11.677

3.  Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reports.

Authors:  Mônica Cássia Firmida; Elizabeth Andrade Marques; Robson Souza Leão; Rosana Helena Vicente Pereira; Elenice Rosa Aguiar Rodrigues; Rodolpho Mattos Albano; Tania Wrobel Folescu; Vagner Bernardo; Pedro Daltro; Domenico Capone; Agnaldo José Lopes
Journal:  Respir Med Case Rep       Date:  2017-01-16

4.  Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis.

Authors:  Migle Gabrielaite; Jennifer A Bartell; Niels Nørskov-Lauritsen; Tacjana Pressler; Finn C Nielsen; Helle K Johansen; Rasmus L Marvig
Journal:  J Clin Microbiol       Date:  2021-03-19       Impact factor: 5.948

5.  Case of recurrent Achromobacter xylosoxidans bacteraemia and PICC (peripherally-inserted central catheter) line infection in an immunocompromised patient.

Authors:  Elaine Houlihan; Mary Lucey; Aruna Pandian; Belinda Hanahoe; Frances Higgins; Niall DeLappe; Janusz Krawczyk; Deirbhile Keady
Journal:  Infect Prev Pract       Date:  2022-01-21

6.  Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients.

Authors:  Laura Veschetti; Angela Sandri; Cristina Patuzzo; Paola Melotti; Giovanni Malerba; Maria M Lleo
Journal:  Microb Genom       Date:  2021-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.